Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.340
+0.010 (0.75%)
At close: Jan 8, 2026, 4:00 PM EST
1.350
+0.010 (0.75%)
Pre-market: Jan 9, 2026, 8:00 AM EST
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $94.74 million as of January 9, 2026. Its market cap has decreased by -38.19% in one year.
Market Cap
94.74M
Enterprise Value
54.98M
1-Year Change
-38.19%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $94.74M, a decrease of -80.63%. That is a compound annual growth rate of -29.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 94.74M | 8.06% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 956.09B |
| Johnson & Johnson | 495.81B |
| AbbVie | 394.13B |
| UnitedHealth Group | 314.78B |
| AstraZeneca | 280.51B |
| Merck & Co. | 271.53B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |